News Headlines Article

New Hepatitis C Pill Promises Faster Treatment, At A Higher Cost
National Public Radio

The FDA has approved a once-a-day pill that combines two drugs to treat hepatitis C, the deadly virus that attacks the liver and is believed to infect 3.2 million Americans.

The new product brings several advances, but it also has a steep price tag, reported at $1,125 per tablet. NPR’s Michaeleen Doucleff reports: “The treatment, made by Gilead Sciences, bypasses the need for any injections or older drugs that have serious side effects. “The therapy is called Harvoni, and it combines two new drugs into a single pill that’s taken once a day.